Announcement, Research Update | 10.31.17 Parker Institute for Cancer Immunotherapy Researchers Present Findings on Pancreatic Cancer, Tumor Vaccines and CAR-T at 2017 Society for Immunotherapy of Cancer Annual Meeting
Press Release | 10.16.17 Dana-Farber Cancer Institute Joins the Parker Institute for Cancer Immunotherapy
Press Release | 09.20.17 The Parker Institute for Cancer Immunotherapy and the Cancer Research Institute Announce First Patients Treated in Pancreatic Cancer Clinical Trial Combining Immunotherapy and Chemotherapy
Research Update | 09.07.17 UCLA Study Shows Virus Plus Immunotherapy Hold Promise for Advanced Melanoma
Announcement, Point of View | 07.12.17 Using Yourself to Fight Cancer with Jeff Bluestone, President and CEO of the Parker Institute for Cancer Immunotherapy
Press Release | 06.22.17 The Parker Institute for Cancer Immunotherapy Trains the Next Generation of Scientific Leaders in Cancer Immunotherapy
Press Release | 06.19.17 Tessa Therapeutics and Parker Institute for Cancer Immunotherapy Enter into Strategic Alliance Agreement